ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 635,20
0,54%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Navidea Biopharmaceuticals Inc (CE) (NAVB)

  7. Navidea Biopharmaceuticals Inc (CE) (NAVB) Actualités

NAVB

Navidea Biopharmaceuticals (CE) (NAVB)

Navidea Biopharmaceuticals Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:NAVB
DateHeureSourceTitreSymboleSociété
06/02/202401h53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202423h28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202423h27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202423h26Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/01/202419h53Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
21/11/202300h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
13/11/202320h58Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/05/201415h47Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
10/12/201315h33Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
24/04/201315h36Dow Jones NewsNavidea Sells More Shares to J.P. Morgan's Asset Management Unit and Another Institutional InvestorAMEX:NAVBNavidea Biopharmaceuticals Inc.
04/04/201315h03Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHAMEX:NAVBNavidea Biopharmaceuticals Inc.
30/01/201316h10Dow Jones NewsNavidea Biopharmaceuticals Sells 1.5 Million Shares at $3.10 EachAMEX:NAVBNavidea Biopharmaceuticals Inc.
 Showing the most relevant articles for your search:USOTC:NAVB

Dernières Valeurs Consultées

NASDAQ
DRMAW
Dermata Therapeutics
BIT
UC525G
Unicredit Bank
BIT
UC9151
Unicredit Bank
BIT
F12738
Vontobel Financial Produ...
LSE
1062
NASDAQI
RNEW
VanEck Green Infrastruct...
BIT
S32556
Societe Generale Effekten
BIT
F13921
Vontobel Financial Produ...
NASDAQ
IIIV
i3 Verticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés